These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 33893295)

  • 1. COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system.
    Rysz S; Al-Saadi J; Sjöström A; Farm M; Campoccia Jalde F; Plattén M; Eriksson H; Klein M; Vargas-Paris R; Nyrén S; Abdula G; Ouellette R; Granberg T; Jonsson Fagerlund M; Lundberg J
    Nat Commun; 2021 Apr; 12(1):2417. PubMed ID: 33893295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic disorder perspective of an interplay between the renin-angiotensin-aldosterone system and SARS-CoV-2.
    Elrashdy F; Redwan EM; Uversky VN
    Infect Genet Evol; 2020 Nov; 85():104510. PubMed ID: 32853823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2, ACE2 expression, and systemic organ invasion.
    Ashraf UM; Abokor AA; Edwards JM; Waigi EW; Royfman RS; Hasan SA; Smedlund KB; Hardy AMG; Chakravarti R; Koch LG
    Physiol Genomics; 2021 Feb; 53(2):51-60. PubMed ID: 33275540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review.
    Ingraham NE; Barakat AG; Reilkoff R; Bezdicek T; Schacker T; Chipman JG; Tignanelli CJ; Puskarich MA
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32341103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme as a new immunologic target for the new SARS-CoV-2.
    Hallaj S; Ghorbani A; Mousavi-Aghdas SA; Mirza-Aghazadeh-Attari M; Sevbitov A; Hashemi V; Hallaj T; Jadidi-Niaragh F
    Immunol Cell Biol; 2021 Feb; 99(2):192-205. PubMed ID: 32864784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum ACE2, Angiotensin II, and Aldosterone Levels Are Unchanged in Patients With COVID-19.
    Rieder M; Wirth L; Pollmeier L; Jeserich M; Goller I; Baldus N; Schmid B; Busch HJ; Hofmann M; Kern W; Bode C; Duerschmied D; Lother A
    Am J Hypertens; 2021 Apr; 34(3):278-281. PubMed ID: 33043967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation.
    Augustine R; S A; Nayeem A; Salam SA; Augustine P; Dan P; Maureira P; Mraiche F; Gentile C; Hansbro PM; McClements L; Hasan A
    Chem Biol Interact; 2022 Jan; 351():109738. PubMed ID: 34740598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
    Kuba K; Yamaguchi T; Penninger JM
    Front Immunol; 2021; 12():732690. PubMed ID: 35003058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
    Shukla AK; Banerjee M
    High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-Angiotensin-Aldosterone Inhibitors and COVID-19 Infection.
    Tsampasian V; Corballis N; Vassiliou VS
    Curr Hypertens Rep; 2022 Oct; 24(10):425-433. PubMed ID: 35716247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2).
    Xiang Y; Wang M; Chen H; Chen L
    Biochem Pharmacol; 2021 Oct; 192():114724. PubMed ID: 34371003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of renin-angiotensin system and COVID-19: the importance of daily rhythms in ACE2, ADAM17 and TMPRSS2 expression.
    Zlacká J; Stebelová K; Zeman M; Herichová I
    Physiol Res; 2021 Dec; 70(S2):S177-S194. PubMed ID: 34913351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19.
    Haslbauer JD; Stalder A; Zinner C; Bassetti S; Mertz KD; Went P; Matter M; Tzankov A
    Pathobiology; 2022; 89(3):166-177. PubMed ID: 34915500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
    Datta PK; Liu F; Fischer T; Rappaport J; Qin X
    Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lock, Stock and Barrel: Role of Renin-Angiotensin-Aldosterone System in Coronavirus Disease 2019.
    Zanza C; Tassi MF; Romenskaya T; Piccolella F; Abenavoli L; Franceschi F; Piccioni A; Ojetti V; Saviano A; Canonico B; Montanari M; Zamai L; Artico M; Robba C; Racca F; Longhitano Y
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID-19.
    Rothlin RP; Vetulli HM; Duarte M; Pelorosso FG
    Drug Dev Res; 2020 Nov; 81(7):768-770. PubMed ID: 32356926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The RAAS and SARS-CoV-2: A riddle to solve].
    Choi M; Aiello EA; Ennis IL; Villa-Abrille MC
    Hipertens Riesgo Vasc; 2020; 37(4):169-175. PubMed ID: 32527699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of the Renin-Angiotensin-Aldosterone System (RAA) in Patients Infected with SARS-CoV-2-Possible Clinical Consequences.
    Dettlaff-Pokora A; Swierczynski J
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19.
    Kutz A; Conen A; Gregoriano C; Haubitz S; Koch D; Domenig O; Bernasconi L; Mueller B; Schuetz P
    Eur J Endocrinol; 2021 Apr; 184(4):543-552. PubMed ID: 33539316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the RAAS in mediating the pathophysiology of COVID-19.
    Jasiczek J; Doroszko A; Trocha T; Trocha M
    Pharmacol Rep; 2024 Jun; 76(3):475-486. PubMed ID: 38652364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.